Quick Takeaways
- Ann D. Rhoads has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,741,634.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Ann D. Rhoads and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GMED | GLOBUS MEDICAL INC | Director | $1,307,640 | -$1,402,600 | -52% | 21 Jan 2026 |
| QDEL | QuidelOrtho Corp | Director | $433,994 | +$21,206 | +5.1% | 10 Dec 2025 |
| RPTX | Repare Therapeutics Inc. | Director | $0 | 28 Jan 2026 | ||
| EVOK | Evoke Pharma Inc | Director | 05 May 2021 | |||
| ITOS | iTeos Therapeutics, Inc. | Director | 29 Aug 2025 | |||
| QDEL | QUIDEL CORP /DE/ | Director | 27 May 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|